Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.

Gillessena S., Attard G., Beer T. M. , Beltran H., Bjartell A., Bossi A., ...More

European urology, vol.77, no.4, pp.508-547, 2020 (Journal Indexed in SCI Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 77 Issue: 4
  • Publication Date: 2020
  • Doi Number: 10.1016/j.eururo.2020.01.012
  • Title of Journal : European urology
  • Page Numbers: pp.508-547
  • Keywords: Advanced prostate cancer, High-risk localised prostate cancer, Hormone-sensitive prostate cancer, Castration-resistant prostate cancer, Oligometastatic prostate cancer, Progression-free survival, Overall survival, Prostate cancer treatment, Imaging, Genetics, Tumour genomic profiling, ANDROGEN-DEPRIVATION THERAPY, SALVAGE RADIATION-THERAPY, LYMPH-NODE DISSECTION, QUALITY-OF-LIFE, HOT FLASHES, RADICAL PROSTATECTOMY, CLINICAL-TRIALS, FREE SURVIVAL, PHASE-II, TESTOSTERONE MEASUREMENTS


Background: Innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced Prostate Cancer Consensus Conference (APCCC) 2019 addressed some of these topics to supplement guidelines that are based on level 1 evidence.